This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
11-04 :: April/May 2011


nanotimes


Companies Facts


ingredients, and consumer product actives, including fragrances, conditioners, sunscreens and hair care actives.


http://www.sdgpharma.com http://www.nanofilmtechnology.com


N


anogate AG (ISIN DE000A0JKHC9) returns to profitability with record sales. That is because


the company benefited from the sharp growth in demand and the newly acquired equity holding in GfO AG. Sales increased by 95.7% to EUR20.9 milli- on, the adjusted EBIT figure came to EUR1.0 million (EBIT before adjustment: EUR-0.2 million). In the financial year 2011, sales are scheduled to increase to more than EUR30 million.


Furthermore, Nanogate is acquiring the Dutch com- pany Eurogard B.V. and thereby considerably expan- ding its position on the market for high-performance surfaces. The newly acquired equity holding is a lea- ding supplier of coatings for two-dimensional com- ponents and the number one in the global specialist market for transparent plastics of high optical quality. http://www.nanogate.de


N


ano Mask Inc. (PINKSHEETS: NANM) has entered into an licensing agreement with Noble


Biomaterials, Inc., from whom Nano Mask will license Noble‘s X-STATIC®


technology to use in their


lab coats and operating room jackets. Nano Mask has contracted Georgia based Encompass Group LLC to manufacture these new products.


X-STATIC® fibers are permanently bonded with a


layer of 99.9% pure metallic silver. This silver layer is the key to powerful antimicrobial and anti-odor pro-


perties, as it creates an ionic shield that permanently inhibits the growth of bacteria and fungi on the fa- bric. Fabrics made with X-STATIC fibers are flexible, with the natural look and feel of traditional textiles, while offering all the benefits of pure silver.


“We have already started taking orders of the new X-STATIC®


based laboratory coats and have placed


our first order with Encompass; we expect additional orders of the lab coats and warm-up jackets,” said Ed Suydam, President and CEO, Nano Mask. http://www.nanoprotectionsolutions.com


N


anometrics Incorporated (NASDAQ: NANO), a leading provider of advanced process control


metrology systems, announced financial results for its first quarter ended April 2, 2011. Revenues were $62.1 million, up 35% from $46.1 million in the fourth quarter of 2010 and up 67% from $37.2 mil- lion in the first quarter of 2010. Gross margin incre- ased to 56.6%, from 52.7% in the prior quarter and 55.3% in the year-ago period. Our operating margin increased to 27.5%, from 18.8% in the prior quarter and 16.0% in the year-ago period.


Net income was $10.5 million or $0.45 per share, compared to $5.9 million or $0.26 per share in the first quarter of 2010. In the fourth quarter of 2010, net income of $26.1 million or $1.12 per share included the favorable impact of the release of $18.2 million in income tax deferred asset valuation allo- wances, equivalent to $0.78 per share. Excluding this tax benefit, the average effective income tax rate for fiscal year 2010 was approximately 7%, whereas net income for the first quarter reflects an effective income tax rate of approximately 35%.


37


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93